Usefulness of a Single-lead Electrocardiographic Recording System and Wireless Transmission During the COVID-19 Pandemic

Carlos López, Dario Carlos Di Toro, Claudio Hadid, Leonardo Celano, Edgar Antezana, Leandro HEFFNER, Agostina Bruno, Clarisa Gashua, Marcelo ZYLBERMAN, Carlos Labadet

Abstract


Background: Some therapies used for COVID-19 can prolong the QT interval and produce severe arrhythmias. QT interval measuredfrom a standard electrocardiogram (ECG) requires additional personnel and risk of infection. Novel technologies to obtain anECG connected to smartphones provide an alternative for the evaluation of corrected QT interval (QTc).Objective: The aim of this study was to evaluate the feasibility of using a single-lead ECG device to measure the QT interval in patientswith suspected or confirmed COVID-19 before receiving treatment with drugs that can prolong the QT interval.Methods: The ECG was obtained with a KardiaMobile (KM) device and transmitted to a smartphone. The ECG recordings weresaved as pdf files and electronically submitted to the electrophysiology section which centralized the reception and assessed themeasured QT and QTc intervals.Results: A total of 31 patients (mean age 61 years, range 20-95 years) with suspected COVID-19 enrolled for treatment with hydroxychloroquine,azithromycin, ritonavir or lopinavir were analyzed. The recordings could be read in all the cases and had to be repeatedin two cases. The mean value of the QTc interval was 423 ms (range 380-457 ms) in men and 439 ms (range 391-540 ms) in women.The response time since the ECG recording was submitted for analysis was 11 min (range 1-155).Conclusions: The QTc interval could be measured from ECG recordings obtained with KM devices connected to a smartphone andtransmitted to a centralized reading center in all patients.

References


Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 2020; May 1, e201834 http://doi.org/10.1001/jamacardio.2020.1834

Bessière F, Roccia H, Delinière, A., Charrière R., Chevalier P., Argaud, L., & Cour, M. (2020). Assessment of QT Intervals in a

Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit. JAMA Cardiol 2020; e201787.http://doi.org/10.1001/jamacardio.2020.178.

National Institute for Clinical Excellence (NICE). AliveCor Heart

Monitor and AliveECG app (Kardia Mobile) for Detecting Atrial Fibrillation

Available online: https://www.nice.org.uk/advice/mib35.

Muhlestein JB. QTC intervals can be assessed with the AliveCor heart monitor in patients on dofetilide for atrial fibrillation. J Electrocardiol

;48:10-1. http://doi.org/10.1016/j.jelectrocard.2014.11.007

Tisdale JE, Jayes HA, Kingery JR, Mourad NA, Trujillo TN,

Overholser BR, et al. Development and validation of a risk score

to predict QT interval prolongation in hospitalized patients. Circ

Cardiovasc Qual Outcomes 2013;6:479-87. http://doi.org/10.1161/CIRCOUTCOMES.113.000152

Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353-70.

Kligfield P, Tyl B, Maarek M, Maison-Blanche P. Magnitude,

mechanism, and reproducibility of QT interval differences between super imposed global and individual lead ECG complexes. Ann Noninvas Electrocardiol. 2007;12:145-52.

Kligfield P, Tyl B, Maarek M, Maison-Blanche P. Magnitude,

mechanism, and reproducibility of QT interval differences between superimposed global and individual lead ECG complexes. Ann Noninvas Electrocardiol 2007;12:145-52. http://doi.org/10.1111/j.1542-474X.2007.00153.x

Karacan M, Celik N, Gul EE, Akdeniz C, Tuzcu V.Validation of

a smartphone-based electrocardiography in the screening of QT

intervals in children. North Clin Istanb 2019;6:48-52. http://doi.

org/10.14744/nci.2018.44452

Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, et al. Assessment of the 12-Lead ECG as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12–25 Years of Age). Circulation 2014;130:1303-34.

http://doi.org/10.1161/CIR.0000000000000025

Mc Loughlin MJ. Precordial bipolar leads: A new method to study anterior acute myocardial infarction. J Electrocardiol 2020; 59:45-64.http://doi.org/10.1016/j.jelectrocard.2019.12.017

Marston HR, Hadley R, Banks D, Duro MDCM. Mobile Self-

Monitoring ECG Devices to Diagnose Arrhythmia that Coincide with Palpitations: A Scoping Review. Healthcare (Basel) 2019 7:96. http://doi.org/10.3390/healthcare7030096

Simpson TF, Kovacs RJ, Stecker EC. Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19. Cardiology Magazine 2020;Mar 29. Disponible en: https://www.acc.org/latest-in cardiology/articles/2020/03/27/14/00/ventriculararrhythmia-

risk-due-to-hydroxychloroquine-azithromycin-treatmentfor-

covid-19.


Full Text

Refbacks

  • There are currently no refbacks.


Licencia Creative Commons
The documents published in this journal are under the licencia Creative Commons Atribución-NoComercial-Compartir-Igual 2.5 Argentina.

Revista argentina de cardiología. ISSN en línea 1850-3748. Argentine journal of cardiology (English ed. Online ISSN 2314-2286) Sociedad Argentina de Cardiología. Azcuénaga 980 (C1115AAD),Ciudad Autónoma de Buenos Aires, República Argentina. Tel. (54 11) 4961-6027/8/9 Fax: 4961-6020 www.sac.org.ar revista@sac.org.ar